Xeomin 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FT2GX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,599
Award facts
- Contract value 100% obligated
- $10,598.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Xeomin 200 Unit Vials under a firm fixed-price contract valued at $10,598.94, with an ultimate completion date of December 26, 2025. This is a non-set-aside competitive award issued on December 4, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. Xeomin (incobotulinumtoxinA) is a botulinum toxin product used for medical and cosmetic applications, and this order reflects AmerisourceBergen's role in ensuring supply chain continuity for specialized pharmaceutical products across the federal health system.
Quick answers
Who was awarded contract SPE2DR26FT2GX?
SPE2DR26FT2GX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FT2GX worth?
The government has obligated $10,599 on SPE2DR26FT2GX.
Is contract SPE2DR26FT2GX an order under another contract?
Yes. SPE2DR26FT2GX is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2GX competed?
The extent of competition for SPE2DR26FT2GX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award